Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H12ClN3O3 |
Molecular Weight | 329.738 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1N=C(C2=CC=CC=C2Cl)C3=CC(=CC=C3NC1=O)[N+]([O-])=O
InChI
InChIKey=LMUVYJCAFWGNSY-VIFPVBQESA-N
InChI=1S/C16H12ClN3O3/c1-9-16(21)19-14-7-6-10(20(22)23)8-12(14)15(18-9)11-4-2-3-5-13(11)17/h2-9H,1H3,(H,19,21)/t9-/m0/s1
Molecular Formula | C16H12ClN3O3 |
Molecular Weight | 329.738 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Meclonazepam (Ro11-3128 or 3-methylclonazepam) is a benzodiazepine derivative. It exerts anxiolytic activity. Meclonazepam demonstrated anti-schistosomal action, it causes spastic paralysis, calcium influx and tegumental disruption in the parasites. Contracturant effect of meclonazepam is not a result of its binding to the worm benzodiazepine binding sites.
CNS Activity
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:59:19 GMT 2023
by
admin
on
Fri Dec 15 16:59:19 GMT 2023
|
Record UNII |
RN43209SMA
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Meclonazepam
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4912
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY | |||
|
C83911
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY | |||
|
DTXSID10207366
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY | |||
|
SUB08680MIG
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY | |||
|
CHEMBL1908326
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY | |||
|
100000081758
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY | |||
|
RN43209SMA
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY | |||
|
58662-84-3
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY | |||
|
3033985
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY | |||
|
C020602
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY | |||
|
MECLONAZEPAM
Created by
admin on Fri Dec 15 16:59:19 GMT 2023 , Edited by admin on Fri Dec 15 16:59:19 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ENANTIOMER |
|
||
|
TARGET ORGANISM->INHIBITOR |
Meclonazepam was never marketed because of sedative effects.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|